A new research paper was published in Genes & Cancer on February 5, 2023, entitled, "Mechanistically based blood proteomic markers in the TGF-β pathway stratify risk of hepatocellular cancer in patients with cirrhosis."
The overall cancer risk was higher in individuals with T2D at a younger age, and the risk decreased as age increased at diagnosis, a prospective study in China found.
Telephone outreach and secure messaging have better response rates than mailed letters when communicating updated colonoscopy intervals for patients with a history of low-risk adenomas.